Transluminal angioplasty was first described by Dotter and Judkins in 1964. They used coaxial catheters, but the technical limitations prevented its widespread acceptance until Gruntzig introduced the double lumen balloon catheter in 1976. This was both effective and easy to use, and established angioplasty as an acceptable technique for the treatment of vascular stenoses in most large arteries in the body. The simplicity and low associated morbidity have subtly altered the indications for intervention, but full clinical assessment of the patient and discussion with a vascular surgeon are essential before angioplasty is considered. There is no place for direct referral from a physician to a radiologist without consultation with a surgeon.
Mechanism of dilatation
The stretching of the artery splits the intima, cracks the atheromatous plaques, and stretches -and sometimes ruptures -the media, causing local dissection and subintimal haemorrhage. Healing occurs by fibrosis and giant cell reaction with formation of neointima, resulting in a smooth lumen within a few weeks.
Angioplasty of peripheral arteries
Percutaneous transluminal angioplasty has been successfully used for the ._ = . . Popliteal artery -The results in the popliteal arteries are similar to those balloon dilatation.
in the superficial femoral arteries, the two year patency rate for the treatment ofocclusions being between 60% and 70%. Extreme care must be taken, however, with stenoses in the distal popliteal artery because damage may result in occlusion of one or more of the crural vessels.
Angioplasty compared with operation
It is difficult to compare angioplasty with operation. On the whole, operation is reserved for more diffuse disease and angioplasty for localised Percutaneous transluminal angioplasty is:
stenoses. Mortality associated with angioplasty is negligible and morbidity * Useful in localised disease is low, whereas mortality after operation ranges from 1% to 5% depending those patients who require an additional procedure proximally, and angioplasty avoids retroperitoneal dissection of the iliac artery.
Angioplasty combined with other techniques Fibrinolysis
Thrombolytic agents such as streptokinase can dissolve a recent thrombus in an artery and convert a long occlusion into a short stenosis that can be dilated by a balloon catheter. In one series the initial success rate was reported as 78% and the two year cumulative patency rate 81%, but the use of thrombolytic agents is not without risk. Complications such as diffuse bleeding and allergic reactions may be fatal. A low dose local infusion of streptokinase (5000 U/hour) reduces the systemic effect and can be useful before angioplasty in patients who are not suitable for operation. Urokinase and tissue plasminogen activator are more specific, and are not associated with allergic reactions, but they are 20 times more expensive than streptokinase. Furthermore, the current data do not show that they have any particular practical advantage. Laser assisted angioplasty
The "hot tip" laser converts the laser energy into heat at the metal tip of Laser used to create a channel. A balloon the laser fibre which burns atheroma inside the artery. Other systems use can then be used to dilate the track. i more direct laser energy and produce less damage to the vessel wall. Laser treatment was hailed as an important advance in the ablation of atheroma, but the long term results are worse than for conventional balloon procedures. The current use of lasers is limited to long occlusions in which the laser probe is used to create a channel through which balloon catheters can be advanced and balloon angioplasty done. BMJ VOLUME 304
